Glimepiride/metformin - Laboratorios SilanesAlternative Names: GLI/METXR; Glimepiride/metformin extended release -Laboratorios Silanes; Glimetal Lex; Metformin extended release/glimepiride -Laboratorios Silanes
Latest Information Update: 25 May 2016
At a glance
- Originator Laboratorios Silanes
- Class Antihyperglycaemics; Biguanides; Small molecules; Sulfones; Sulfonylureas
- Mechanism of Action AMP activated protein kinase stimulants; Gluconeogenesis inhibitors; Insulinotropin agonists; Potassium channel antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Type 2 diabetes mellitus